As @CampbellJAustin puts it: when it comes to securing RWAs, the answer is Avalanche’s L1 architecture. https://t.co/xRf84xaZgV ...

Which RWA altcoin are you most bullish on this Altseason?$LINK or $ONDO https://t.co/mQWD1ehAZO ...

🏦 DeFi Brief:Aave launches Horizon for institutional RWA borrowing with Circle, Ethena, OpenEden. Jupiter Lend goes public with new assets + higher LTVs. Hyperbeat tokenizes delta-neutral positions. Ethena adds BNB as USDe collateral.5/6 https://t.co/tGujr4z6H9 ...

Core Viewpoint - The pharmaceutical industry, particularly biotech companies, is expected to experience a significant market upturn from late 2024 to mid-2025, supported by global market growth and strong performance in the Chinese pharmaceutical market [1][3]. Market Trends - The rapid growth of BD (business development) activities, the reopening of the Sci-Tech Innovation Board, and the performance of Hong Kong's secondary market indicate that the industry is entering a valuation recovery phase [1]. - Despite some biotech companies experiencing substantial stock price increases, many investors have not yet recouped their costs due to the timing of investments [1][2]. Investment Landscape - High-quality companies that address clinical needs are more likely to survive market downturns, while many biotech firms have failed to navigate the recent market challenges [2]. - The current secondary market appears prosperous, but from the perspective of primary market entrepreneurs, it is still in a winter phase [2]. Challenges and Opportunities - The difficulty of listing biotech companies in both China and the U.S. has led to diversified financing channels, with investors focusing on asset quality and clinical research data [3]. - The demand for high-quality, cost-effective products is increasing due to global aging populations and limited healthcare funding [4]. Global Positioning - Chinese innovators have significantly narrowed the development gap with the U.S., with a reported 38% year-on-year increase in overseas licensing deals, totaling $60.8 billion in the first half of 2025 [5][6]. - The shift from generic to original drug development in China is expected to have a profound impact on the global pharmaceutical market [6]. R&D Efficiency - China leads globally in R&D efficiency from "1 to 10," while the U.S. remains dominant in "0 to 1" development [6]. - The ability to produce unique products, particularly in ADC (antibody-drug conjugates), is attributed to China's strong engineering capabilities [9]. Future Growth Areas - The most promising research areas for capital investment are in immunology and metabolic/cardiovascular fields [7]. - The market is witnessing a divide, with leading companies leveraging innovation and digital empowerment, while smaller firms face greater pressure due to homogenized competition [6][10]. Strategic Directions - Companies are encouraged to explore new financing models, such as RWA (Real World Asset) tokenization, to better access markets [11]. - The focus on license-out opportunities and the promotion of inclusive healthcare are critical strategies for pharmaceutical companies [12].

Group 1 - The core viewpoint of the news is the strategic cooperation between Ruihe Digital Technology Holdings Limited and Tielin Superlight Technology Co., Ltd. to promote the digital issuance of real-world assets (RWA) in the renewable energy sector [1][2] - The collaboration focuses on a benchmark project involving a renewable energy power station with a total capacity exceeding 60MW and an investment of over 250 million RMB, expected to generate annual revenue exceeding 40 million RMB [2][3] - This partnership represents a significant step for Ruihe Digital in the RWA field, leveraging Tielin Superlight's quality underlying asset resources and operational experience to enhance market competitiveness and profitability [3] Group 2 - The project aims to create a replicable and scalable model for RWA applications, providing important scenario support for the implementation of RWA with stable and sustainable returns from renewable energy assets [2][3] - Both companies plan to expand their market influence by offering RWA issuance technology and business consulting services for various types of physical assets in Hong Kong and overseas markets [2][3] - The integration of physical assets and digital technology in RWA is expected to inject significant financial resources into the real economy, particularly in capital-intensive industries, promoting high-quality economic development [3]

Financial Performance - Company reported total revenue of 5.422 billion yuan for the first half of 2025, a year-on-year increase of 15.29% [1] - Net profit attributable to shareholders reached 519 million yuan, up 26.42% year-on-year [1] - In Q2 2025, total revenue was 2.489 billion yuan, reflecting an 8.75% increase year-on-year, while net profit was 266 million yuan, a 19.08% increase [1] Key Financial Ratios - Gross margin improved to 26.93%, an increase of 6.2% year-on-year [1] - Net margin rose to 11.24%, up 8.66% year-on-year [1] - Total expenses (selling, administrative, and financial) amounted to 728 million yuan, accounting for 13.42% of revenue, a decrease of 16.73% year-on-year [1] Balance Sheet Insights - Current ratio stands at 0.95, indicating increased short-term debt pressure [1] - Cash and cash equivalents increased to 4.638 billion yuan, a 27.39% rise year-on-year [1] - Interest-bearing liabilities rose to 20.04 billion yuan, a 17.72% increase year-on-year [1] Earnings Per Share and Cash Flow - Earnings per share (EPS) increased to 0.33 yuan, a 29.04% rise year-on-year [1] - Operating cash flow per share remained at 0.56 yuan, a slight decrease of 1.01% year-on-year [1] Investment Returns and Business Model - Company’s return on invested capital (ROIC) was 4.52%, indicating weak capital returns [3] - Historical data shows a median ROIC of 7.37% over the past decade, with three years of losses [3] - Business model heavily relies on capital expenditures, necessitating scrutiny of capital spending projects [3] Debt and Cash Flow Concerns - Cash flow situation is concerning, with cash to current liabilities ratio at 39.02% [3] - Debt situation is critical, with interest-bearing debt ratio at 37.73% and current ratio at 0.95 [3] - Accounts receivable to profit ratio reached 1018.14%, indicating potential liquidity issues [3] Analyst Expectations - Analysts project 2025 earnings to reach 900 million yuan, with an average EPS forecast of 0.55 yuan [3]

Real World Asset (RWA) Tokenization - RWA on-chain value has increased by almost 10% in the last 30 days [1] - The value on public networks is almost $16 billion, a 10.62% jump in the last 30 days [1] - Since the beginning of the year, the total RWA value on public networks has almost doubled, adding approximately $9 billion [1] - Stable coin market cap is up 54% in the last 30 days, equivalent to $210 million [1] - Clear Bank estimates that 2.2% of $2.2 quadrillion worth of equities, bonds, real estate, and derivatives will be tokenized [10][13] XRP Ledger and Derivatives - XRP ledger has grown substantially over the last 30 days, up 21.45%, almost $25 million [1] - Derivatives have always been a main focus for the XRP ecosystem due to the value tied to them [2][4] - Ripple's acquisitions and partnerships support the development of derivatives on the XRP ledger [8] - XRP ledger EVM side chain enables more use cases and supports advanced derivatives [4][7][8] Coinbase and Tokenization - Coinbase is developing an "everything exchange" to tokenize equities and other assets [1] - Coinbase aims to offer millions of assets, derivatives, and tokenized equities in one place [1] - Coinbase believes all assets will inevitably move on-chain [1] Market Cap and Valuation - Traditional market cap valuations may not accurately reflect the potential value of blockchain networks [22][23][26] - The value moving on-chain, TVL, and DeFi activities should be considered when evaluating the potential of projects [26] - The tokenization of $2.2 quadrillion could shift the market perspective and increase the value of projects like XRP [21][28]

Core Viewpoint - The company aims to shift its focus towards international business due to favorable market opportunities and strong demand in the global market [2] Financial Performance - In the first half of 2025, the company achieved a revenue of 797 million yuan, a year-on-year increase of 12.2% [2] - The steel trading volume reached 63.8 billion yuan, with a transaction volume exceeding 19.1 million tons [2] - The overall gross profit for the first half of 2025 was 182 million yuan, with contributions from trading services, trading support services, and technology subscription services being 67%, 7.8%, and 6.2% respectively [2] International Business Development - The international business revenue for the first half of 2025 was 340 million yuan, reflecting a year-on-year growth of 38.9% [3] - The trading volume in international business reached 71,000 tons, with a year-on-year increase of 58.0% [3] - The gross profit from international business was 29 million yuan, showing a year-on-year increase of 90.5% [3] - The company has established subsidiaries in several countries including the UAE, Saudi Arabia, Thailand, Malaysia, and Indonesia to enhance its overseas operations [3] Non-Steel Business Expansion - The company has diversified into non-steel sectors, including electronics and non-ferrous metals, with the e-commerce platform for non-ferrous metals currently in trial operation [6] - In the first half of 2025, the gross merchandise volume (GMV) for the non-steel business reached 210 million yuan, a year-on-year increase of 23.0% [6] - The AI commercialization capabilities have improved, with the AI trading assistant and other data assets being developed [6][7] Financial Technology Initiatives - The company has re-entered the financial technology sector through a partnership with Chongqing Fumin Bank, focusing on data and transaction scenarios without bearing actual risks [7] - The new financial model aims to generate data-related income while minimizing risk exposure [7] Future Outlook - The company expresses confidence in future growth, anticipating significant profitability from both domestic and international operations in the coming years [7]

Aave 🤝 ChainlinkProud to be working with you on creating the biggest RWA market in DeFi.Stani.eth (@StaniKulechov):Fastest growing RWA market in DeFi. ...

Investment Rating - The report maintains a "Buy" rating for the company [1] Core Views - The company achieved a total revenue of 1.603 billion yuan in the first half of 2025, representing a year-on-year increase of 21.1%, and a net profit attributable to shareholders of 214 million yuan, up 4.5% year-on-year, which aligns with market expectations [7] - The company continues to steadily advance its two main businesses: industrial energy conservation and building energy conservation, with respective year-on-year revenue growth of 27.7% and 5.0% in the first half of 2025 [7] - The company is focusing on "deep decarbonization" and leveraging digital and intelligent technologies to create a new energy ecosystem that integrates energy production, storage, transportation, and consumption [7] - The company has upgraded its digital management platform, covering the entire lifecycle of project management, and has successfully managed over 1,100 projects and 2,902 users [7] - The report forecasts net profits attributable to shareholders of 477 million yuan, 557 million yuan, and 675 million yuan for 2025, 2026, and 2027 respectively, with corresponding P/E ratios of 38, 32, and 27 [7] Financial Summary - The total revenue forecast for 2025 is 3.576 billion yuan, with a year-on-year growth rate of 13.36% [1] - The projected net profit for 2025 is 477 million yuan, reflecting a significant year-on-year increase of 920.50% [1] - The earnings per share (EPS) for 2025 is estimated at 0.13 yuan, with a P/E ratio of 37.57 [1]